Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
The mechanism of action of interferon-β in relapsing multiple sclerosis.
Retinal architecture and mfERG: Optic nerve head component response characteristics in MS.
Advances in Antioxidative Therapy of Multiple Sclerosis.
The elusive biomarker for personalized medicine in multiple sclerosis: The search continues.
A randomized, double-blind, phase 2 study of erythropoietin in optic neuritis.
The combination of cyclophosphamide plus interferon beta as rescue therapy could be used to treat relapsing-remitting multiple sclerosis patients-- twenty-four months follow-up.
Chronic oligodendrogenesis and remyelination after spinal cord injury in mice and rats.
Association between parasite infection and immune responses in multiple sclerosis.
Effect of IL-17A blockade with secukinumab in autoimmune diseases.
Going Against the Tide - How Encephalitogenic T Cells Breach the Blood-Brain Barrier.
K(+) channel alterations in the progression of experimental autoimmune encephalomyelitis.
A low vitamin D status at diagnosis is associated with an early conversion to secondary progressive multiple sclerosis.
Shared HLA Class II in Six Autoimmune Diseases in Latin America: A Meta-Analysis.
Cyclophosphamide in chronic progressive multiple sclerosis: a comparative study.
Development and characterization of a clinically compliant xeno-free culture medium in good manufacturing practice for human multipotent mesenchymal stem cells.
Multiple Sclerosis: Changes in Microarchitecture of White Matter Tracts after Training with a Video Game Balance Board.
Neuroprotective agent riluzole potentiates postsynaptic GABA(A) receptor function.
Delta-9-tetrahydrocannabinol + cannabidiol. A reasonable option for some patients with multiple sclerosis.
The Symbol Digit Modalities Test as sentinel test for cognitive impairment in multiple sclerosis.
Overview of the epidemiology, diagnosis, and disease progression associated with multiple sclerosis.
FTY720 attenuates excitotoxicity and neuroinflammation.
The pathogenic role of the inflammasome in neurodegenerative diseases.
Energy conservation for fatigue management in multiple sclerosis: a pilot randomized controlled trial.
Vaccination against autoimmune encephalomyelitis with T-lymphocyte line cells reactive against myelin basic protein.
Bayesian inferences for beta semiparametric-mixed models to analyze longitudinal neuroimaging data.
Pages
« first
‹ previous
…
202
203
204
205
206
207
208
209
210
…
next ›
last »